Synergistic protective effects of escin and low‑dose glucocorticoids on blood‑retinal barrier breakdown in a rat model of retinal ischemia

Zhang,Fenglan; Li,Yuanbin; Zhang,Leiming; Mu,Guoying

doi:10.3892/mmr.2013.1374

Synergistic protective effects of escin and low‑dose glucocorticoids on blood‑retinal barrier breakdown in a rat model of retinal ischemia

Authors:
- Fenglan Zhang
- Yuanbin Li
- Leiming Zhang
- Guoying Mu
View Affiliations

Affiliations: Department of Ophthalmology, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China, Department of Ophthalmology, Yantai Yuhuangding Hospital, Yantai, Shandong 264001, P.R. China, Department of Pharmacology, School of Pharmacy, Yantai University, Yantai, Shandong 264005, P.R. China
Published online on: March 15, 2013 https://doi.org/10.3892/mmr.2013.1374
Pages: 1511-1515

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Escin, a natural mixture of triterpenoid saponins isolated from the seed of the horse chestnut (Aesculus hippocastanum), has been demonstrated to possess glucocorticoid (GC)‑like anti‑edematous and anti‑inﬂammatory effects. The aim of the present study was to investigate whether escin exhibits synergistic protective effects on blood‑retinal barrier (BRB) breakdown when combined with GCs in a rat model of retinal ischemia. Low concentrations of escin and triamcinolone acetonide (TA) alone did not affect BRB permeability. However, when administered together, low‑dose escin and TA significantly reduced BRB permeability following ischemia. Furthermore, low‑dose escin and TA alone did not affect the expression of occludin in the ischemic retina; however, when administered together, they significantly increased occludin expression in the ganglion cell layer of the ischemic retina. This indicates that escin and GCs have synergistic protective effects on BRB breakdown and the molecular mechanisms may be correlated with the upregulation of occludin. Therefore, the administration of escin may allow a reduction in the dose of GCs for the treatment of macular edema. The combination of escin with GCs is potentially a beneficial treatment method for BRB breakdown and warrants further investigation.

View Figures

View References

1	Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T and Girach A: Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye (Lond). 18:963–983. 2004. View Article : Google Scholar : PubMed/NCBI
2	Ehrlich R, Harris A, Ciulla TA, Kheradiya N, Winston DM and Wirostko B: Diabetic macular oedema: physical, physiological and molecular factors contribute to this pathological process. Acta Ophthalmol. 88:279–291. 2010. View Article : Google Scholar : PubMed/NCBI
3	Stewart MW: Corticosteroid use for diabetic macular edema: old fad or new trend? Curr Diab Rep. 12:364–375. 2012. View Article : Google Scholar : PubMed/NCBI
4	Liu L, Wu X, Geng J, Yuan Z and Chen L: IVTA as adjunctive treatment to PRP and MPC for PDR and macular edema: a meta-analysis. PLoS One. 7:e446832012. View Article : Google Scholar : PubMed/NCBI
5	Wilson CA, Berkowitz BA, Sato Y, Ando N, Handa JT and de Juan E Jr: Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol. 110:1155–1159. 1992. View Article : Google Scholar : PubMed/NCBI
6	Felinski EA, Cox AE, Phillips BE and Antonetti DA: Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element. Exp Eye Res. 86:867–878. 2008. View Article : Google Scholar : PubMed/NCBI
7	Jonas JB, Kreissig I and Degenring R: Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol. 87:24–27. 2003. View Article : Google Scholar : PubMed/NCBI
8	Jonas JB, Degenring R, Vossmerbauemer U and Kamppeter B: Frequency of cataract surgery after intravitreal injection of high-dosage triamcinolone acetonide. Eur J Ophthalmol. 15:462–464. 2005.PubMed/NCBI
9	Fu F, Hou Y, Jiang W, Wang R and Liu K: Escin: inhibiting inflammation and promoting gastrointestinal transit to attenuate formation of postoperative adhesions. World J Surg. 29:1614–1620. 2005. View Article : Google Scholar : PubMed/NCBI
10	Zhang L, Fu F, Zhang X, Zhu M, Wang T and Fan H: Escin attenuates cognitive deficits and hippocampal injury after transient global cerebral ischemia in mice via regulating certain inflammatory genes. Neurochem Int. 57:119–127. 2010. View Article : Google Scholar
11	Wang T, Fu F, Zhang L, Han B, Zhu M and Zhang X: Effects of escin on acute inflammation and the immune system in mice. Pharmacol Rep. 61:697–704. 2009. View Article : Google Scholar : PubMed/NCBI
12	Zhang L, Wang H, Fan H, et al: The potent anti-inflammatory agent escin does not increase corticosterone secretion and immune cell apoptosis in mice. Fitoterapia. 82:861–867. 2011. View Article : Google Scholar : PubMed/NCBI
13	Xin W, Zhang L, Sun F, et al: Escin exerts synergistic anti-inflammatory effects with low doses of glucocorticoids in vivo and in vitro. Phytomedicine. 18:272–277. 2011. View Article : Google Scholar : PubMed/NCBI
14	Gong YY, Yu SQ, Wang H, et al: Clinical therapy of retinal vein occlusion with aescuven forte. Chin J New Drugs Clin Rem. 24:965–967. 2005.(In Chinese).
15	Wang WJ, Gong YY, Wang H, et al: Aescuven forte in treating central serous chorioretinopathy. Chin J New Drugs Clin Rem. 24:961–964. 2005.(In Chinese).
16	Yuan Y and Wu L: Clinical observation of the central serous chorioretinopathy treated by aescinate sodium tablets combined with argon laser. Guiding Journal of TCM and Pharmacology. 15:58–59. 2009.(In Chinese).
17	Berenbaum MC: What is synergy? Pharmacol Rev. 41:93–141. 1989.PubMed/NCBI
18	Tsujikawa A, Ogura Y, Hiroshiba N, et al: Retinal ischemia-reperfusion injury attenuated by blocking of adhesion molecules of vascular endothelium. Invest Ophthalmol Vis Sci. 40:1183–1190. 1999.PubMed/NCBI
19	Yilmaz T, Celebi S and Kükner AS: The protective effects of melatonin, vitamin E and octreotide on retinal edema during ischemia-reperfusion in the guinea pig retina. Eur J Ophthalmol. 12:443–449. 2002.PubMed/NCBI
20	Furuse M, Hirase T, Itoh M, et al: Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol. 123:1777–1788. 1993. View Article : Google Scholar
21	Xu HZ and Le YZ: Significance of outer blood-retina barrier breakdown in diabetes and ischemia. Invest Ophthalmol Vis Sci. 52:2160–2164. 2011. View Article : Google Scholar : PubMed/NCBI